# Takeda triples capacity of cell therapy plant in Tres Cantos, Spain

Takeda has tripled the production capacity of its plant in Tres Cantos, Madrid, for the allogeneic cell therapy for Crohn's disease, with a €10.6 million investment.

- Type: Expansion
- Announced: 2021-09-28
- Where: Tres Cantos, Madrid, Spain
- Value: $12.4M (10.6M EUR)
- Status: completed
- Products: allogeneic cell therapy, stem cell therapy for Crohn's disease
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda](https://endata.com/companies/52956.md)

## Sources

- [takeda.com](https://www.takeda.com/es-es/sala-de-prensa/2021/takeda-triplica-la-capacidad-de-su-planta-de-fabricacion-en-espana-para-asumir-el-aumento-de-demanda-mundial-de-la-primera-terapia-celular-alogenica/), 2021-09-28: "Con una inversión de 10,6 millones de euros, la multinacional japonesa ha ampliado las instalaciones de esta planta para poder asumir el aumento de la demanda del medicamento 'vivo' comercializado."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.